Clare L V Westhorpe1, Hans G Schneider2, Mandy Dunne1, Tracey Middleton3, Vijaya Sundararajan4, Tim Spelman1, Vanessa Carter5, Suzanne M Crowe1, Anthony Dart6, Anne Mijch7, Despina Kotsanas8, Ian Woolley7. 1. Macfarlane Burnet Institute for Medical Research and Public Health, Prahran, Vic. 3004, Australia. 2. Alfred Pathology Service, Alfred Health, Commercial Road, Prahran, Vic. 3004, Australia. 3. Victorian Infectious Diseases Reference Laboratory, Wreckyn Street, North Melbourne, Vic. 3051, Australia. 4. Department of Human Services Victoria, Lonsdale Street, Melbourne, Vic. 3000, Australia. 5. Department of Nutrition, The Alfred Hospital, Commercial Road, Prahran, Vic. 3004, Australia. 6. Department of Cardiology, The Alfred Hospital, Commercial Road, Prahran, Vic. 3004, Australia. 7. Department of Medicine, Central and Eastern Clinical School, Monash University, Melbourne, Vic. 3004, Australia. 8. Department of Infectious Diseases, Monash Health, Clayton Road, Clayton, Vic. 3168, Australia.
Abstract
UNLABELLED: Background In some studies HIV infection confers approximately two-fold higher risk of cardiac events compared with the general population. C-reactive protein (CRP) is a well-characterised biomarker of cardiac events in the general population and is also elevated in patients with HIV infection. The aim of this study was to determine the predictive value of CRP for cardiac events in HIV-infected individuals. METHODS: We retrospectively analysed CRP levels in stored plasma samples from HIV-infected patients who did or did not experience a coronary event in a case-controlled manner. All CRP measurements were performed using a high-sensitivity assay (hs-CRP). RESULTS: Of the study participants with samples available, we found slightly elevated hs-CRP levels in the cardiac cases (median 3.5, IQR 1.6-14.4, n=23) compared with controls (median 2.6, IQR1.2-8.3, n=49) which were shown to not be statistically significant P=0.20. Analysis of CRP as a binary variable (≥5mgL(-1)) was also not statistically significant (OR: 1.32, 95% CI 0.48-3.63). CONCLUSIONS: CRP levels may indicate elevated risk of future cardiac events, however this must be interpreted with caution due to the generalised elevation of CRP during HIV infection. CRP has no predictive value for atherosclerosis, and further research is required to improve early prediction of cardiovascular disease in HIV infection.
UNLABELLED: Background In some studies HIV infection confers approximately two-fold higher risk of cardiac events compared with the general population. C-reactive protein (CRP) is a well-characterised biomarker of cardiac events in the general population and is also elevated in patients with HIV infection. The aim of this study was to determine the predictive value of CRP for cardiac events in HIV-infected individuals. METHODS: We retrospectively analysed CRP levels in stored plasma samples from HIV-infectedpatients who did or did not experience a coronary event in a case-controlled manner. All CRP measurements were performed using a high-sensitivity assay (hs-CRP). RESULTS: Of the study participants with samples available, we found slightly elevated hs-CRP levels in the cardiac cases (median 3.5, IQR 1.6-14.4, n=23) compared with controls (median 2.6, IQR1.2-8.3, n=49) which were shown to not be statistically significant P=0.20. Analysis of CRP as a binary variable (≥5mgL(-1)) was also not statistically significant (OR: 1.32, 95% CI 0.48-3.63). CONCLUSIONS:CRP levels may indicate elevated risk of future cardiac events, however this must be interpreted with caution due to the generalised elevation of CRP during HIV infection. CRP has no predictive value for atherosclerosis, and further research is required to improve early prediction of cardiovascular disease in HIV infection.
Authors: John E Lewis; Jillian Poles; Eleanor Garretson; Eduard Tiozzo; Sharon Goldberg; Carmen S G Campbell; Herbert G Simões; Judi M Woolger; Janet Konefal Journal: Am J Lifestyle Med Date: 2020-02-11
Authors: Vivien Leung; Ya-Lin Chiu; Donald P Kotler; Jeanine Albu; Yuan-Shan Zhu; Kirsis Ham; Ellen S Engelson; Hoda Hammad; Paul Christos; Daniel S Donovan; Henry N Ginsberg; Marshall J Glesby Journal: HIV Clin Trials Date: 2016-02-01
Authors: Joanne LaFleur; Adam P Bress; Lisa Rosenblatt; Jacob Crook; Paul E Sax; Joel Myers; Corey Ritchings Journal: AIDS Date: 2017-09-24 Impact factor: 4.177
Authors: Gerrit Kann; Junaid Owasil; Karina Kuczka; Annette Haberl; Timo Wolf; Pavel Khaykin; Sebastian Harder; Christoph Stephan; Nils von Hentig Journal: HIV AIDS (Auckl) Date: 2021-08-06